Breadcrumb
  1. Home
  2. About HRSA
  3. Were there different permissible uses of funds received as quality incentive payments compared to those for the funds distributed previously under the $2.5 billion Nursing Home Infection Control Distribution?

Were there different permissible uses of funds received as quality incentive payments compared to those for the funds distributed previously under the $2.5 billion Nursing Home Infection Control Distribution?

Were there different permissible uses of funds received as quality incentive payments compared to those for the funds distributed previously under the $2.5 billion Nursing Home Infection Control Distribution?

No. The same Terms and Conditions and restrictions on use of funds applied to the quality incentive payments received by nursing homes as under the Nursing Home Infection Control Distribution. Quality incentive payments could only be used for the infection control expenses, as that term is defined in the Terms and Conditions. These include costs associated with administering COVID-19 testing for both staff and residents; reporting COVID-19 test results to local, state, or federal governments; hiring staff to provide patient care or administrative support; incurring expenses to improve infection control, including activities such as implementing infection control “mentorship” programs with subject matter experts, or changes made to physical facilities; and providing additional services to residents, such as technology that permits residents to connect with their families if the families are not able to visit in person.

(Modified 12/14/2020)

Nursing Home Infection Control
Date Last Reviewed: